NCT01401985View on ClinicalTrials.gov

A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2012

Conditions
Opioid Induced Constipation
Interventions
DRUG

TD-1211

Capsules

DRUG

Placebo

Capsules

Trial Locations (1)

91105

Theravance Biopharma Investigational Site, Pasadena

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY

NCT01401985 - A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC) | Biotech Hunter | Biotech Hunter